Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000485572 | SCV000572814 | uncertain significance | not provided | 2021-08-31 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 29345414, 23862152) |
Ce |
RCV000485572 | SCV002063228 | pathogenic | not provided | 2021-12-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000485572 | SCV002240880 | pathogenic | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 409 of the TYRP1 protein (p.Ala409Val). This variant is present in population databases (rs148248971, gnomAD 0.006%). This missense change has been observed in individual(s) with oculocutaneous albinism (PMID: 29345414). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 423157). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TYRP1 protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. |
Molecular Diagnostics Laboratory, |
RCV003322776 | SCV004028494 | likely pathogenic | Oculocutaneous albinism type 3 | 2023-04-11 | criteria provided, single submitter | clinical testing |